Enhancing the effect of radioimmunotherapy in the treatment...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/506 (2006.01) A61K 9/50 (2006.01) A61K 39/395 (2006.01) A61K 41/00 (2006.01) A61K 51/10 (2006.01) A61P 35/00 (2006.01) A61K 47/26 (2006.01)

Patent

CA 2492878

4- (4-methylpiperazin-1-ylmethyl) -N- [4-methyl-3- (4-pyridin-3-yl) pyrimidin- 2-ylamino) phenyl]- benzamide of the formula I or a pharmaceutically acceptable salt thereof can be used for enhancing the effect of radioimmnotherapy of tumors.

L'invention concerne un 4-(4-méthylpiperazin-1-ylméthyl)-N-[4-méthyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide représenté par la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, pouvant être utilisé pour renforcer l'effet de la radioimmunothérapie des tumeurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enhancing the effect of radioimmunotherapy in the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancing the effect of radioimmunotherapy in the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancing the effect of radioimmunotherapy in the treatment... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1567689

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.